It’s more than just robots — it’s automating decision-making processes to manage costs, enhance efficiency, build resilience and navigate a volatile labor market. For shippers and receivers of goods ...
The $4.8 billion acquisition of Amicus Therapeutics by BioMarin is, on its surface, a familiar healthcare story: portfolio expansion, accelerated revenue Discover how BioMarin's acquisition impacts ...
Finish the year with a clearer view of the freight landscape in the December Edge Report from C.H. Robinson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback